![](/img/cover-not-exists.png)
The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia a comparison of three versus six courses
Daniel M. Green, Martin L. Brecher, Leslie E. Blumenson, Mauro Grossi, Arnold I. FreemanVolume:
50
Year:
1982
Language:
english
Pages:
6
DOI:
10.1002/1097-0142(19821215)50:123.0.co;2-t
File:
PDF, 523 KB
english, 1982